On this week’s Tech Nation, it’s about developing medicines which enable the body to heal itself. First up, treating depression in a whole new way … and rapidly. Dr. Jeff Jonas, the Chief Innovation Officer and Director of Sage Therapeutics, talks about their drug Zuranolone, nearing the end of its drug approval journey. Then, Craig Parker, the CEO of Surrozen, talks about their work with the W-N-T pathway, or Wnt pathway. Their initial candidate for treatment? Repairing the liver.

On this week’s Tech Nation, Moira speaks with ROBERT SIEGEL, Venture Investor and Stanford University Lecturer, and the Author of “The Brains and Brawn Company … How Leading Organizations blend the best of Digital and Physical.” Then, intervening with “cytokine storms”. JIM JOYCE, the CEO of San Diego’s Sigyn Therapeutics talks about their progress to intervening quickly.

On this week’s Tech Nation, Moira speaks with journalist Oliver Broudy about his book “The Sensitives - The Rise of Environmental Illness and Search for America’s Last Pure Place.” Then in biotech, a San Diego company who pivoted from treating parainfluenza and influenza to target COVID … and they started in Wuhan, China. Moira speaks with Dr. Stanley Lewis, the Chief Medical Officer of Ansun Biopharma.

Moira speaks with journalist Jason Fagone talks about Elizebeth Smith Friedman, a pioneer in codebreaking, from World War I to rumrunners to drug smuggling to the famous Enigma machine. His book is “The Woman Who Smashed Codes: A True Story of Love, Spies, and the Unlikely Heroine Who Outwitted America’s Enemies.”

Then on Tech Nation Health, Dr. Marco Taglietti, President and CEO of Scynexis, talks about their work in serious invasive fungal infections.

On this week’s Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US. Then MIKE CLAYMAN, the CEO of Flexion Therapeutics, talks about the treatments they have in clinical trials for osteoarthritis, knee replacement surgery, and more.

On this week’s Tech Nation, Moira speaks with Dr. Levi Garraway, the Chief Medical Officer of Genentech about FDA approvals for treatments in two very rare diseases - SMA - Spinal Muscular Atrophy, and NMOSD - Neuromyelitis Optica Spectrum Disorder. Then Dr. Thomas Rando, Co-Founder of Fountain Therapeutics, a Professor at Stanford University School of Medicine, and Director of Glen Laboratories on the Biology of Aging talks about a rampant medical condition – aging.

On this week’s Tech Nation, Moira speaks with anthropologist EBEN KIRKSEY, a professor of anthropology at Deakin University in Melbourne. He’s look at the societal and ethical implications of CRISPR – and not just hypothetically. He traveled to China, with an eye to understanding the circumstance of the three CRISPR babies known to exist. His book is “The Mutant Project: Inside the Global Race to Genetically Modify Humans”. Then Tech Nation Health Chief Correspondent Dr. Daniel Kraft gives us a quick primer on antibodies and how we use them as therapy.

On this week’s Tech Nation, Moira speaks with psychologist Dr. Ron Friedman about “Decoding Greatness … How the Best in the World Reverse Engineer Success”. Then Dr. Tom Hallam from Palisade Bio in San Diego talks about their efforts to solve a major problem post-surgery – how to get your GI track back on track. And Tech Nation Health Chief Correspondent Dr. Daniel Kraft reviews tests to detect Alzheimer’s early.

On this week’s Tech Nation, Moira speaks with Tanuj (“Ta-nooj”) Mohan, the Co-Founder and Chief Technology Officer of Enlighted, a Siemens Company based in Silicon Valley. Smart technology may bring us back to safe workplaces - from social distancing, to automatic contact tracing, overly crowded points of contact, and more. Then Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about our “Sociome” – where and how we live is more important than our DNA.

On this week’s Tech Nation, what we lose if we go to driverless cars. Moira speaks with Matthew Crawford about his book: “Why We Drive … Toward a Philosophy of the Open Road”. Then Yochi Slonim, CEO of Anima Biotech, talks about the path from your DNA to producing proteins, and the potential for new drugs.